You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR DEUTETRABENAZINE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for DEUTETRABENAZINE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01795859 ↗	First Time Use of SD-809 in Huntington Disease	Completed	Teva Branded Pharmaceutical Products R&D, Inc.	Phase 3	2013-08-05	The purpose of this study is to determine whether SD-809 tablets are effective in the treatment of chorea associated with Huntington's Disease.
NCT01795859 ↗	First Time Use of SD-809 in Huntington Disease	Completed	Teva Pharmaceutical Industries	Phase 3	2013-08-05	The purpose of this study is to determine whether SD-809 tablets are effective in the treatment of chorea associated with Huntington's Disease.
NCT01897896 ↗	Alternatives for Reducing Chorea in Huntington Disease	Completed	Auspex Pharmaceuticals, Inc.	Phase 3	2013-11-12	The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of SD-809 extended release (ER) in participants switching from tetrabenazine to SD-809 ER. In addition, the safety and tolerability of long-term treatment with SD-809 ER will be assessed in "Switch" participants as well as "Rollover" participants completing a randomized, double blind, placebo-controlled study of SD-809 ER.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DEUTETRABENAZINE

Condition Name

Chart
Table

Condition Name for DEUTETRABENAZINE
Intervention	Trials
TOURETTE SYNDROME	4
Huntington Disease	3
Tardive Dyskinesia	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DEUTETRABENAZINE
Intervention	Trials
Huntington Disease	5
Tourette Syndrome	4
Syndrome	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DEUTETRABENAZINE

Trials by Country

Map
Table

Trials by Country for DEUTETRABENAZINE
Location	Trials
United States	189
Poland	7
Canada	7
Ukraine	4
Hungary	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for DEUTETRABENAZINE
Location	Trials
Tennessee	10
Texas	10
Missouri	9
Florida	9
Alabama	9
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DEUTETRABENAZINE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DEUTETRABENAZINE
Clinical Trial Phase	Trials
Phase 3	8
Phase 2/Phase 3	3
Phase 1/Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DEUTETRABENAZINE
Clinical Trial Phase	Trials
Completed	8
Recruiting	5
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DEUTETRABENAZINE

Sponsor Name

Chart
Table

Sponsor Name for DEUTETRABENAZINE
Sponsor	Trials
Teva Branded Pharmaceutical Products R&D, Inc.	8
Teva Branded Pharmaceutical Products, R&D Inc.	6
Auspex Pharmaceuticals, Inc.	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DEUTETRABENAZINE
Sponsor	Trials
Industry	23
Other	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.